#SNIPAFRICA has officially kicked off! 👏

We're excited to announce this new African-European collaboration, funded by Global Health EDCTP3. Through an adaptive platform trial, we will identify optimal antibiotic regimens & doses for neonatal sepsis treatment.

More➡️ penta-id.org/press-releases…

Important findings from the NeoOBS study published in PLOS Medicine highlighting need for improved treatment of neonatal sepsis globally

Eager to know more about our #NeoSep1 #clinicaltrial ? 👀

Check out the latest episode of the Trial Talk podcast, by MRC Clinical Trials Unit at UCL! 🎙️

St George's, University of London
Antimicrobial Resistance Research Team | CNPI
Laboratory of Medical Microbiology UA

Each year, 35 million newborns worldwide are born preterm or small for gestational age, and may be low birthweight.

In our latest issue, a new Lancet Series sets out recommendations to reverse this trajectory: hubs.li/Q01QtcLs0 #SmallVulnerableNewborns

Really excited to be part of this important project

(1/5) Neonatal sepsis affects up to 3 million babies every year, mostly in low- and middle-income countries.

But growing antimicrobial resistance #AMR is making it harder to treat.

About 40% of infections are now resistant to standard antibiotics 💊

Can we identify markers of epidemiologically successful MRSA in different European countries? Here is what we found! sciencedirect.com/science/articl…

In case you missed it: Women are less likely to be credited for their scientific contributions than men. It’s true across multiple fields & at all stages, with important repercussions for career progress. #WomenInSTEM #WomenInMedicine #MedTwitter

nature.com/articles/s4158…

Great work team and Happy #InternationalClinicalTrialsDay 👏🏻

Last week at #ESPID2023

#MyESPID #Vancomycin #Neonates Antimicrobial Resistance Research Team | CNPI SGUL Infect Immunity St George's, University of London

Clinical lecturer post for public health trainees SGUL Infect Immunity . Come and work with us on #vaccines oriel.nhs.uk/Web/Vacancy/Va…

International clinical trials day 2023

A huge thank you to the NeoVTAMR nurses on #InternationalNursesDay who helped recruit all mums & babies to this trial in Zomba, Malawi 🇲🇼despite many challenges, including the devastating Cyclone Freddy.

You are amazing & we couldn’t have done it without you! 🥼🏥

#NursesDay

Recently published OpTIMUM study (The Lancet Microbe) being highlighted at the Matenal Vaccination: Policy & Practice session at #ESPID2023 . OpTIMUM supports pertussis vaccination in pregnant women any time between 16 weeks & 32 weeks gestation to protect their babies
St George's Vaccine Institute

Networking at the beautiful Estufa Fria de Lisboa

#myESPID

Team building at #ESPID2023

#MyESPID #Lisboa Antimicrobial Resistance Research Team | CNPI

Great talk on barriers to vaccination in pregnancy by Anna Calvert St George's Vaccine Institute. Delivery of info important-when&who. Safe inclusion of women in vaccine trials needed to increase evidence. Active engagement with Mums from diverse groups essential

#ESPID2023 ESPIDSociety

Dr Anna Calvert presenting results from the IMPS study. Incidence of invasive meningococcal disease higher in preterm infants but presentation and disease course comparable with term babies
#ESPID2023 St George's Vaccine Institute SGUL Infect Immunity St George's, University of London ESPIDSociety

#Snotwatch Time & Space KDets 👩‍🚀 - Kawasaki disease-pre&post pandemic surveillance in VIC, Aus. HMPV&RSV assoc with KD pre-pandemic but viral associations not identified during pandemic. SARS-CoV-2 not found to be associated #ESPID2023 Rana Sawires Monash University Murdoch Children's Research Institute (MCRI)

Upendo Mseka - Malawian cholera outbreak. Sequencing, serosurveillance, & epi surveillance to inform response & vaccine policy. Empower community health centres to analyse own data. Overall vaccine uptake low due to access not hesitancy 🇲🇼
Malawi Liverpool Wellcome Programme #ESPID2023 ESPIDSociety